Commercial Forecasting, Portfolio Strategy & Advisory for Life Sciences

Clearer commercial thinking
for portfolio and forecasting decisions.

DSX helps biotech and specialty pharma leadership teams make better portfolio, forecasting and BD&L decisions through commercially grounded analysis, explicit assumptions and constructive challenge.

Book a 30-minute scoping discussion See how DSX works

Supporting decisions across

Biotech Specialty Pharma Rare Disease BD&L Portfolio Strategy

How DSX works

Structure before analysis.
Decisions before models.

Every engagement follows four stages designed to improve the strength of the decision being made.

01

Define the decision

Clarify the strategic question, the assumptions that matter most and the uncertainties that could change the outcome.

02

Build the framework

Set out the commercial structure before detailed modelling begins, including market definition, competition, pricing, access and adoption.

03

Stress-test the assumptions

Explore how the answer changes under different scenarios, not just under a single set of inputs.

04

Deliver the decision pack

Provide clear models, documented assumptions and materials that support leadership and governance discussions.

Why DSX

More analysis is easy. Clear judgement is harder.

Clear assumptions

Forecasts built on transparent, explicit assumptions rather than hidden logic.

International commercial perspective

Commercial thinking shaped by how pricing, access and competition play out across markets.

Governance preparation

Clear materials, scenario frameworks and supporting assumptions built for leadership and governance discussions.

Independent perspective

Senior-level constructive challenge to strengthen forecasts and strategy when the assumptions matter most.

Services

DSX works with organisations
where commercial assumptions
directly influence important decisions.

Forecast Architecture

The framework behind the model matters.

Forecast architecture is the commercial structure that sits behind a forecast model.

  • Market definition and patient segmentation
  • Competitive evolution and pipeline modelling
  • Pricing and access dynamics across regions
  • Adoption pathways and physician behaviour
  • Scenarios and ranges
  • Governance decision support
Explore Forecast Architecture
Portfolio Strategy

Portfolio choices need a clear commercial view.

Portfolio decisions shape where and when capital get deployed and how an asset is positioned over time.

  • Indication prioritisation and sequencing
  • Competitive positioning and pipeline mapping
  • Global launch sequencing strategy
  • Portfolio risk evaluation
  • Scenario planning
Explore Portfolio Strategy
Strategic Advisory

Independent perspective for important commercial decisions.

Senior-level advisory support to leadership teams that want independent challenge, clearer commercial thinking and practical input as decisions evolve.

  • Portfolio governance and strategic direction
  • Forecast review and stress-testing
  • Commercial and BD&L Decision Support
  • Market and competitive evolution
  • Governance discussion preparation
Explore Strategic Advisory

Use Cases

For the commercial decisions that matter most.

01

Indication prioritisation

Assess which indications offer the strongest commercial opportunity.

02

Portfolio strategy & pipeline positioning

Support portfolio choices with a clearer view of competition, timing and market potential.

03

Commercial forecasting

Build forecasting frameworks with clear assumptions for leadership decisions.

04

BD&L opportunity evaluation

Assess the commercial case for licensing and partnership opportunities.

05

Governance & investment committee support

Prepare clear materials for leadership, governance and investment discussions.

06

Launch timing & market entry planning

Compare market sequencing options across pricing, access and competitive dynamics.

Working with DSX

Senior-led and focused on your
most important decisions.

Senior-led
work
International
perspective
Governance
materials
20+ years
experience

Engagement formats

  • Diagnostic Review 2–3 weeks
  • Forecast Framework Build 4–8 weeks
  • Strategic Advisory Ongoing

DSX typically works with

  • Biotech leadership teams making important portfolio and investment decisions
  • Specialty pharma teams preparing for major commercial or governance discussions
  • BD&L teams assessing assets, indications and partnership opportunities
  • Organisations that need clear forecasts and commercial thinking for senior review

Client perspectives

Leadership teams who needed
clarity, not more analysis.

All case studies

Frequently asked

FAQ

DSX works with biotech and specialty pharma teams, BD&L groups, and portfolio leaders making important commercial decisions. Engagements are selective and usually focused on situations where clearer forecasting, portfolio thinking or commercial challenge will make a meaningful difference.
Forecast architecture is the commercial framework behind a forecast. It covers how the market is defined, how competition is expected to evolve, how pricing and access affect uptake, and which assumptions drive the outcome. DSX focuses on making that framework clear before detailed modelling begins.
A diagnostic review usually takes 2 to 3 weeks. A larger forecasting or portfolio engagement typically takes 4 to 8 weeks. Strategic advisory support is more flexible and can run over a longer period depending on the client’s needs.
Yes. DSX brings experience across US, UK and European commercial environments, including pricing and access, HTA-driven markets, rare disease settings and launch sequencing across regions. That international perspective is an important part of the work.
DSX works with commercially sensitive portfolio, forecasting and pipeline information as a matter of course. Every engagement is handled under strict confidentiality, with appropriate NDAs and clear data-handling arrangements put in place from the outset.
BOOK A DISCUSSION

Clearer commercial thinking for important decisions.

If your team is evaluating portfolio choices, refining a forecast or preparing for a major leadership discussion, DSX can help bring sharper commercial judgement to the work.

Book a 30-minute scoping discussion